eanCast: Weekly Neurology

ean.org
undefined
Jan 28, 2024 • 21min

Ep. 81: Stroke and Cardiology: Not Only a Matter of Brain

Moderator: Barbara Tettenborn (St.Gallen, Switzerland) Guest: Matthias Endres (Berlin, Germany) In this episode, Barbara Tettenborn interviews Professor Matthias Endres, professor and chair of Neurology at the Charité Hospital in Berlin. The conversatio Moderator: Barbara Tettenborn (St.Gallen, Switzerland)Guest: Matthias Endres (Berlin, Germany)In this episode, Barbara Tettenborn interviews Professor Matthias Endres, professor and chair of Neurology at the Charité Hospital in Berlin. The conversation delves into the connection between stroke and cardiology. Endres introduces the concept of stroke-induced atrial fibrillation, distinguishing it from pre-existing AF. They discuss the stroke heart syndrome, underlining the increased risk of cardiac events post-stroke. Troponin elevation is highlighted as a crucial biomarker, and the role of insular lesions in the brain in the syndrome is explored. The podcast concludes by emphasizing the importance of an interdisciplinary approach between neurology and cardiology for comprehensive patient care.
undefined
Jan 21, 2024 • 22min

Ep. 80: Rare Causes of Stroke

Moderator: Benedetta Storti (Milan, Italy) Guest: Anita Arsovska (Skopje, North Macedonia) Benedetta Storti hosts Prof. Arsovska as they explore rare causes of strokes, covering conditions like cardiomyopathy, fibromuscular dysplasia, and immune-related Moderator: Benedetta Storti (Milan, Italy)Guest: Anita Arsovska (Skopje, North Macedonia)Benedetta Storti hosts Prof. Arsovska as they explore rare causes of strokes, covering conditions like cardiomyopathy, fibromuscular dysplasia, and immune-related factors. Arsovska stresses the significance of a comprehensive diagnostic approach, discussing specific features in tests and advocating for thorough investigations. The podcast addresses potential errors in diagnostic pathways and underscores the importance of biopsy in certain cases. Arsovska shares insights into tailored treatment options based on underlying conditions.
undefined
Jan 14, 2024 • 18min

Ep. 79: Hidden Hazards: A Dive into Covert Cerebrovascular Disease

Moderator: Barbara Tettenborn (St. Gallen, Switzerland) Guest: Thomas Meinel (Bern, Switzerland) Thomas Meinel, a clinician scientist at the Burn Stroke Research Center in Switzerland, is hosted by Barbara Tettenborn as they discuss covert cerebrovascul Moderator: Barbara Tettenborn (St. Gallen, Switzerland)Guest: Thomas Meinel (Bern, Switzerland)Thomas Meinel, a clinician scientist at the Burn Stroke Research Center in Switzerland, is hosted by Barbara Tettenborn as they discuss covert cerebrovascular disease. His research, particularly on strokes in patients on anticoagulation, is explored, highlighting the frequency and clinical implications of covert cerebrovascular lesions. Meinel emphasizes the current lack of clear evidence for managing these conditions. He also shares insights into ongoing studies that aim to connect epidemiological knowledge with clinical practices, encouraging neurologists to recognize and address covert cerebrovascular disease in patient care.
undefined
Jan 7, 2024 • 24min

Ep. 78: Advocating for Brain Health

Moderator: Rolf Fronczek (Leiden, The Netherlands) Guest: Matilde Leonardi (Milan, Italy) Celebrate the end of the year with us with this special episode on Brain Health! Rolf Fronczek hosts Matilde Leonardi discussing her international neurology career Moderator: Rolf Fronczek (Leiden, The Netherlands)Guest: Matilde Leonardi (Milan, Italy)Celebrate the end of the year with us with this special episode on Brain Health! Rolf Fronczek hosts Matilde Leonardi discussing her international neurology career and passion for Brain Health. She highlights the WHO Global Action Plan on epilepsy, stresses the increasing global burden of neurological diseases, and advocates for preventative measures. Leonardi details EAN's Brain Health Strategy, urging neurologists to advocate for brain health individually and nationally. Emphasizing a bio-psychosocial approach, she invites participation in EAN's leadership and advocacy training to contribute to shaping global brain health.
undefined
Dec 31, 2023 • 18min

Ep. 77: 30th Anniversary of the European Journal of Neurology

Moderator: Barbara Tettenborn (St. Gallen, Switzerland) Guest: Didier Leys (Lille, France) In this eanCast episode, Barbara Tettenborn interviews Didier Leys, Editor-in-Chief of the European Journal of Neurology, marking its 30th anniversary. Leys discu Moderator: Barbara Tettenborn (St. Gallen, Switzerland)Guest: Didier Leys (Lille, France)In this eanCast episode, Barbara Tettenborn interviews Didier Leys, Editor-in-Chief of the European Journal of Neurology, marking its 30th anniversary. Leys discusses the journal's evolution, challenges, and current impact factor of five. He outlines his daily editorial duties, stressing manuscript selection, ethical standards, and team management. Future plans include webinars, a history special issue, a virtual issue of top-cited articles, and video interviews with editors. He also encourages young researchers to submit, citing impact factor and submission delay importance. The episode closes with a glimpse into exciting 30th-anniversary initiatives.
undefined
Dec 24, 2023 • 16min

Ep. 76: Neurological side effects and drug interactions of new antiviral drugs against SARS-CoV-2

Moderator: Johann Sellner (Mistelbach, Austria) Guest: Tamuna Akhvlediani (Tbilisi, Georgia) In this podcast episode, Prof. Johann Sellner interviews Prof. Tamuna Akhvlediani about the neurological aspects of new antiviral drugs for SARS-CoV-2. They dis Moderator: Johann Sellner (Mistelbach, Austria)Guest: Tamuna Akhvlediani (Tbilisi, Georgia)In this podcast episode, Prof. Johann Sellner interviews Prof. Tamuna Akhvlediani about the neurological aspects of new antiviral drugs for SARS-CoV-2. They discuss drugs like monoclonal antibodies, paxlovid, and remdesivir, emphasizing their mechanisms and potential applications beyond COVID-19. Prof. Akhvlediani details neurological side effects observed in trials and significant drug interactions, especially in chronic neurological patients. The episode closes with insights into managing these interactions in clinical practice.
undefined
Dec 17, 2023 • 14min

Ep. 75: Nosocomial Infections of the central nervous system

Moderator: Johann Sellner (Mistelbach, Austria) Guest: Tamuna Akhvlediani (Tbilisi, Georgia) In this last episode on Infectious Diseases, Prof. Johann Sellner and Prof. Tamuna Akhvlediani explore nosocomial infections of the central nervous system (CNS) Moderator: Johann Sellner (Mistelbach, Austria)Guest: Tamuna Akhvlediani (Tbilisi, Georgia)In this last episode on Infectious Diseases, Prof. Johann Sellner and Prof. Tamuna Akhvlediani explore nosocomial infections of the central nervous system (CNS). They cover the definition, common pathogens, and prevention methods like infection control and standardized surgery. Prof. Akhvlediani specifies prevalent CNS infections and addresses challenges in prevention and treatment, notably due to antimicrobial resistance. The conversation concludes with insights into treatment strategies, emphasizing the increasing challenge of antimicrobial resistance in healthcare-associated infections.
undefined
Dec 10, 2023 • 14min

Ep. 74: EBV in the pathogenesis of multiple sclerosis

Moderator: Tamuna Akhvlediani (Tbilisi, Georgia) Guest: Johann Sellner (Mistelbach, Austria) In this week’s podcast hosted by Dr. Tamuna Akhvlediani, Prof. Johann Sellner discusses the connection between Epstein-Barr virus (EBV) and multiple sclerosis ( Moderator: Tamuna Akhvlediani (Tbilisi, Georgia)Guest: Johann Sellner (Mistelbach, Austria)In this week’s podcast hosted by Dr. Tamuna Akhvlediani, Prof. Johann Sellner discusses the connection between Epstein-Barr virus (EBV) and multiple sclerosis (MS). They explore the immune-mediated nature of MS, focusing on the impact of EBV and recent studies linking its infection to MS development. The episode delves into the controversies, hypotheses, and potential therapies related to EBV and MS, concluding with information on ongoing clinical trials and the influence of existing MS treatments on EBV.
undefined
Dec 3, 2023 • 18min

Ep. 73: Neuroinfections in times of COVID-19

Moderator: Tamuna Akhvlediani (Tbilisi, Georgia) Guest: Johann Sellner (Mistelbach, Austria) Dr. Tamuna Akhvlediani hosts Professor Johann Sellner in a podcast discussing the impact of COVID-19 on neuro infections. Professor Sellner covers global neuro Moderator: Tamuna Akhvlediani (Tbilisi, Georgia)Guest: Johann Sellner (Mistelbach, Austria)Dr. Tamuna Akhvlediani hosts Professor Johann Sellner in a podcast discussing the impact of COVID-19 on neuro infections. Professor Sellner covers global neuro infections, the decline during lockdowns, and the effectiveness of measures like face masks and vaccination. The episode emphasizes lessons learned, including insights into chronic neuro infection care disruptions and challenges, such as neuro-AIDS management during the pandemic. It concludes with findings from a study on how COVID-19 affected different neurological subspecialties.
undefined
Nov 26, 2023 • 15min

Ep. 72: Outcome of neurological toxicities of immune checkpoint inhibitors and the effect of drug rechallenge

Moderator: Yildiz Değirmenci (Istanbul, Turkey) Guest: Antonio Farina (Florence, Italy) This week, Dr. Yildiz Değirmenci and Dr. Antonio Farina discuss life-threatening neurological toxicities from immune checkpoint inhibitors. Dr. Farina highlights hig Moderator: Yildiz Değirmenci (Istanbul, Turkey)Guest: Antonio Farina (Florence, Italy)This week, Dr. Yildiz Değirmenci and Dr. Antonio Farina discuss life-threatening neurological toxicities from immune checkpoint inhibitors. Dr. Farina highlights high fatality rates, long-term disabilities, and the urgency of early recognition and treatment. The episodeexplores management, including discontinuation and corticosteroids, and factors influencing outcomes. It touches on the association between adverse events and treatment response, resuming inhibitors, and stresses a multidisciplinary approach for informed decision-making. The conclusion emphasizes the importance of neurologists' awareness in addressing these rare yet significant neurological complications.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app